|
Back to Home » September 2018 News » Targovax Strengthens Management Team With the Appointment of Torbjørn Furuseth as CFO; Erik Digman Wiklund to become CBO |
Targovax Strengthens Management Team With the Appointment of Torbjørn Furuseth as CFO; Erik Digman Wiklund to become CBO |
September 13, 2018
OSLO, Norway, Sept. 13, 2018 /PRNewswire/ -- Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, announces the appointment of Dr. Torbjørn Furuseth as CFO, effective 24 September...
Source URL: https://www.prnewswire.com:443/news-releases/targovax-strengthens-management-team-with-the-appointment-of-torbjorn-furuseth-as-cfo-erik-digman-wiklund-to-become-cbo-300711907.html
|
|
|
|
